132 related articles for article (PubMed ID: 24903325)
21. Pax3 down-regulation and shut-off of melanogenesis in melanoma B16/F10.9 by interleukin-6 receptor signaling.
Kamaraju AK; Bertolotto C; Chebath J; Revel M
J Biol Chem; 2002 Apr; 277(17):15132-41. PubMed ID: 11830592
[TBL] [Abstract][Full Text] [Related]
22. PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma.
Kubic JD; Lui JW; Little EC; Ludvik AE; Konda S; Salgia R; Aplin AE; Lang D
J Biol Chem; 2015 Sep; 290(36):21901-14. PubMed ID: 26205821
[TBL] [Abstract][Full Text] [Related]
23. PAX3 is expressed in human melanomas and contributes to tumor cell survival.
Scholl FA; Kamarashev J; Murmann OV; Geertsen R; Dummer R; Schäfer BW
Cancer Res; 2001 Feb; 61(3):823-6. PubMed ID: 11221862
[TBL] [Abstract][Full Text] [Related]
24. Pax3 transcripts in melanoblast development.
Blake JA; Ziman MR
Dev Growth Differ; 2005 Dec; 47(9):627-35. PubMed ID: 16316407
[TBL] [Abstract][Full Text] [Related]
25. PAX3 and ETS1 synergistically activate MET expression in melanoma cells.
Kubic JD; Little EC; Lui JW; Iizuka T; Lang D
Oncogene; 2015 Sep; 34(38):4964-74. PubMed ID: 25531327
[TBL] [Abstract][Full Text] [Related]
26. FOXD3 Promotes PAX3 Expression in Melanoma Cells.
Kubic JD; Little EC; Kaiser RS; Young KP; Lang D
J Cell Biochem; 2016 Feb; 117(2):533-41. PubMed ID: 26252164
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation of serine 205 by the protein kinase CK2 persists on Pax3-FOXO1, but not Pax3, throughout early myogenic differentiation.
Dietz KN; Miller PJ; Hollenbach AD
Biochemistry; 2009 Dec; 48(49):11786-95. PubMed ID: 19904978
[TBL] [Abstract][Full Text] [Related]
28. P-cadherin is a direct PAX3-FOXO1A target involved in alveolar rhabdomyosarcoma aggressiveness.
Thuault S; Hayashi S; Lagirand-Cantaloube J; Plutoni C; Comunale F; Delattre O; Relaix F; Gauthier-Rouvière C
Oncogene; 2013 Apr; 32(15):1876-87. PubMed ID: 22710718
[TBL] [Abstract][Full Text] [Related]
29. PAX3 expression in normal skin melanocytes and melanocytic lesions (naevi and melanomas).
Medic S; Ziman M
PLoS One; 2010 Apr; 5(4):e9977. PubMed ID: 20421967
[TBL] [Abstract][Full Text] [Related]
30. Conditional immortalization establishes a repertoire of mouse melanocyte progenitors with distinct melanogenic differentiation potential.
Yang K; Chen J; Jiang W; Huang E; Cui J; Kim SH; Hu N; Liu H; Zhang W; Li R; Chen X; Kong Y; Zhang J; Wang J; Wang L; Shen J; Luu HH; Haydon RC; Lian X; Yang T; He TC
J Invest Dermatol; 2012 Oct; 132(10):2479-2483. PubMed ID: 22592154
[No Abstract] [Full Text] [Related]
31. Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.
Vachtenheim J; Novotná H
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1075-82. PubMed ID: 10644012
[TBL] [Abstract][Full Text] [Related]
32. Identification of serines 201 and 209 as sites of Pax3 phosphorylation and the altered phosphorylation status of Pax3-FOXO1 during early myogenic differentiation.
Dietz KN; Miller PJ; Iyengar AS; Loupe JM; Hollenbach AD
Int J Biochem Cell Biol; 2011 Jun; 43(6):936-45. PubMed ID: 21440083
[TBL] [Abstract][Full Text] [Related]
33. PAX3 and PAX3-FKHR promote rhabdomyosarcoma cell survival through downregulation of PTEN.
Li HG; Wang Q; Li HM; Kumar S; Parker C; Slevin M; Kumar P
Cancer Lett; 2007 Aug; 253(2):215-23. PubMed ID: 17350164
[TBL] [Abstract][Full Text] [Related]
34. Pax3 and regulation of the melanocyte-specific tyrosinase-related protein-1 promoter.
Galibert MD; Yavuzer U; Dexter TJ; Goding CR
J Biol Chem; 1999 Sep; 274(38):26894-900. PubMed ID: 10480898
[TBL] [Abstract][Full Text] [Related]
35. Pax3 and hippo signaling coordinate melanocyte gene expression in neural crest.
Manderfield LJ; Engleka KA; Aghajanian H; Gupta M; Yang S; Li L; Baggs JE; Hogenesch JB; Olson EN; Epstein JA
Cell Rep; 2014 Dec; 9(5):1885-1895. PubMed ID: 25466249
[TBL] [Abstract][Full Text] [Related]
36. The PGF(2alpha) receptor FP is lost in nevi and melanoma.
Fricke A; McClelland L; Scott G
Pigment Cell Melanoma Res; 2010 Feb; 23(1):141-3. PubMed ID: 20002888
[No Abstract] [Full Text] [Related]
37. Small molecule inhibition of PAX3-FOXO1 through AKT activation suppresses malignant phenotypes of alveolar rhabdomyosarcoma.
Jothi M; Mal M; Keller C; Mal AK
Mol Cancer Ther; 2013 Dec; 12(12):2663-74. PubMed ID: 24107448
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of melanoma inhibitory activity (MIA) expression in melanoma cells leads to molecular and phenotypic changes.
Tatzel J; Poser I; Schroeder J; Bosserhoff AK
Pigment Cell Res; 2005 Apr; 18(2):92-101. PubMed ID: 15760338
[TBL] [Abstract][Full Text] [Related]
39. Haplosufficiency of PAX3 for melanoma development in Tyr: NRASQ61K; Cdkn2a-/- mice allows identification and sorting of melanoma cells using a Pax3GFP reporter allele.
Campagne C; Reyes-Gomez E; Loiodice S; Gadin S; Ezagal J; Bernex F; Abitbol M; Louise A; Beermann F; Panthier JJ; Aubin-Houzelstein G; Egidy G
Melanoma Res; 2016 Feb; 26(1):12-20. PubMed ID: 26587692
[TBL] [Abstract][Full Text] [Related]
40. Activation of PAX3-MET pathways due to miR-206 loss promotes gastric cancer metastasis.
Zhang L; Xia L; Zhao L; Chen Z; Shang X; Xin J; Liu M; Guo X; Wu K; Pan Y; Fan D
Carcinogenesis; 2015 Mar; 36(3):390-9. PubMed ID: 25653235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
